#financial-decline

[ follow ]
#allbirds
NYC startup
from24/7 Wall St.
2 days ago

Allbirds Is Done: A $4 Billion Brand Sells for $39 Million and Dissolves

Allbirds signed a definitive agreement to sell its assets for $39 million, marking a significant decline from its previous $4 billion valuation.
NYC startup
fromTNW | Business
4 days ago

Allbirds is selling all its assets for $39M

Allbirds is selling its assets and IP to American Exchange Group for $39 million, dissolving after a significant decline in valuation and revenue.
Social media marketing
fromFast Company
1 week ago

Meta stock price falls to nearly 1-year low: 3 reasons why the Facebook parent company is sinking in 2026

Meta Platforms' stock has dropped over 32% since its all-time high due to a recent loss in a social media addiction trial.
E-Commerce
fromwww.pressdemocrat.com
1 month ago

Papa Johns plans to close 300 stores nationwide, Bay Area locations may be impacted

Papa Johns will close 300 underperforming stores by 2027 and lay off 7% of corporate staff due to declining revenue and profitability in the fourth quarter.
Public health
fromSilicon Canals
1 month ago

The early dementia sign that appears 10 years before diagnosis that most people explain away - Silicon Canals

Declining financial management often precedes memory symptoms and can appear up to a decade before a dementia diagnosis.
#susan-powter
fromBasketball Network
4 months ago

"Go through my NBA journey, and end up right back in the same spot" - A broke Sebastian Telfair on going back to live in the projects

I played over 10 years in the NBA and made tens of millions of dollars. I had everything I ever dreamed of. But after a series of legal issues and personal problems, my life has become something I could never have imagined. I'm right back to where it all began - back in Coney Island, back in the projects, back in the fire.
National Basketball Association
fromFuturism
7 months ago

The Maker of Ozempic Is in Such Deep Trouble That It's Going on Hiring Lockdown

Despite ushering in the weight-loss injectable craze and reaching a whopping $604 billion market cap in March 2024, Novo has for the past 18 months suffered hit after financial hit as compounding companies cut into its profit margin by selling cheaper, off-brand Ozempic - and as Eli Lilly, the makers of rival jabs Mounjaro and Zepbound, surged ahead thanks to promising news about its orforglipron GLP-1 pill.
Business
[ Load more ]